Next, to investigate whether extracellularly added CDNF could mitigate platelet-induced pro-inflammatory responses in BV2 microglia, CDNF (1 μg/mL) was administered in the co-culture of BV2 microglial cells and platelets derived from stroke patients. Here, CDNF is linked to stroke disorder.